fluvoxamine (Q409236)

fluvoxamine (English)

19 October 2016

chemical formula

C₁₅H₂₁F₃N₂O₂

1 reference

fluvoxamine (English)

19 November 2016

canonical SMILES

COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F

1 reference

fluvoxamine (English)

19 November 2016

isomeric SMILES

COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F

1 reference

fluvoxamine (English)

https://www.whocc.no/atc_ddd_index/?code=N06AB08

19 November 2016

defined daily dose

0.1 gram

route of administration

oral administration

1 reference

reference URL

1 reference

14 February 2018

World Health Organisation international non-proprietary name

fluvoxamine (English)

1 reference

fluvoxamine (English)

medical condition treated

19 October 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

obsessive-compulsive disorder

13 December 2016

2 references

13 December 2016

Drug Indications Extracted from FAERS

obsessive-compulsive disorder

2 October 2018

start time

19 December 2007

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/O4L1XPO44W

2 November 2018

reference URL

http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021519lbl.pdf

mental depression

0 references

significant drug interaction

isocarboxazid

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

procarbazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(±)-deprenyl

1 reference

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

desmopressin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prostacyclin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cangrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

carbamazepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nausea

1 reference

A reference set of clinically relevant adverse drug-drug interactions

palpitation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vomiting

1 reference

A reference set of clinically relevant adverse drug-drug interactions

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nausea

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vomiting

1 reference

A reference set of clinically relevant adverse drug-drug interactions

palpitation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

xerostomia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urinary retention

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

xerostomia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urinary retention

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

xerostomia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

urinary retention

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ataxia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hyperreflexia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nystagmus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

intention tremor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ataxia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hyperreflexia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nystagmus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

intention tremor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

screaming

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

sinus bradycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

solute carrier family 6 member 4

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7189

LiverTox likelihood score

17 August 2016

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Fluvoxamine

last update

2 February 2018

subject has role

selective serotonin reuptake inhibitor

2 references

5 March 2018

15 March 2018

1 reference

MeSH descriptor ID

D016666

second-generation antidepressive agents

15 March 2018

1 reference

MeSH descriptor ID

D016666

cytochrome P-450 CYP1A2 Inhibitors

15 March 2018

1 reference

MeSH descriptor ID

D016666

cytochrome P-450 CYP2C19 Inhibitors

15 March 2018

1 reference

Institute for Safe Medication Practices

15 March 2018

fluvoxaMINE

1 reference

reference URL

https://www.ismp.org/recommendations/tall-man-letters-list

InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+

2 September 2022

Commons category

Fluvoxamine

0 references

Identifiers

InChI

1 reference

fluvoxamine (English)

19 November 2016

2 references

fluvoxamine (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

54739-18-3

2 references

fluvoxamine (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=54739-18-3

9 April 2021

1 reference

Fluvoxamine (English)

19 November 2016

2 references

fluvoxamine (English)

19 November 2016

Reaxys registry number

5583954

1 reference

fluvoxamine (English)

19 October 2016

ChEBI ID

5138

mapping relation type

2 references

FLUVOXAMINE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+

1 reference

FLUVOXAMINE (English)

19 November 2016

2 references

inferred from InChIKey

splash10-00di-9033000000-d6a8b06f446107932c1c

1 reference

MassBank accession ID

SM851903

0 references

SPLASH

0 references

DSSTox substance ID

DTXSID2044002

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.125.476

27 December 2018

ECHA Substance Infocard ID

(E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine (English)

quotation

CAS no.: 54739-18-3 (English)

100.125.476

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.125.476

27 December 2018

(E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine (English)

quotation

CAS no.: 54739-18-3 (English)

1 reference

Guide to Pharmacology Ligand ID

Fluvoxamine (English)

publication date

17 November 2015

7189

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7189

fluvoxamine (English)

19 November 2016

Fluvoxamine

0 references

0 references

0 references

1 reference

fluvoxamine (English)

19 November 2016

DrugBank ID

DB00176

1 reference

2 references

fluvoxamine (English)

19 November 2016

MedlinePlus drug identifier

0 references

1 reference

fluvoxamine (English)

19 November 2016

0 references

1 reference

1 reference

fluvoxamine (English)

19 October 2016

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

fluvoxamine (English)

19 October 2016

0 references

0 references

1 reference

28 October 2013

1 reference

9 July 2020

Microsoft Academic ID

0 references

1 reference

26 January 2022

1 reference

4ENH (English)

19 October 2016

1 reference

imported from Wikimedia project

4MM9 (English)

19 October 2016

1 reference

1 reference

German Wikipedia

Store medisinske leksikon ID

fluvoksamin

mapping relation type

exact match

subject named as

fluvoksamin

1 reference

Great Norwegian Encyclopedia

5 June 2020

1 reference

fluvoxamine (English)